News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
728,545 Results
Type
Article (41261)
Company Profile (265)
Press Release (687003)
Multimedia
Podcasts (90)
Webinars (20)
Section
Business (204804)
Career Advice (2029)
Deals (35570)
Drug Delivery (128)
Drug Development (81490)
Employer Resources (173)
FDA (16485)
Job Trends (14973)
News (346727)
Policy (32749)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2593)
Accelerated approval (45)
Adcomms (25)
Allergies (167)
Alliances (49580)
ALS (200)
Alzheimer's disease (1764)
Antibody-drug conjugate (ADC) (425)
Approvals (16846)
Artificial intelligence (632)
Autoimmune disease (253)
Automation (52)
Bankruptcy (362)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (217)
Biotechnology (175)
Bladder cancer (184)
Brain cancer (68)
Breast cancer (717)
Cancer (5630)
Cardiovascular disease (455)
Career advice (1720)
Career pathing (41)
CAR-T (316)
CDC (54)
Celiac Disease (2)
Cell therapy (843)
Cervical cancer (45)
Clinical research (70544)
Collaboration (2000)
Company closure (4)
Compensation (1329)
Complete response letters (77)
COVID-19 (2734)
CRISPR (103)
C-suite (1060)
Cystic fibrosis (150)
Data (7500)
Decentralized trials (3)
Denatured (27)
Depression (157)
Dermatology (73)
Diabetes (569)
Diagnostics (6887)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (306)
Drug pricing (198)
Drug shortages (31)
Duchenne muscular dystrophy (273)
Earnings (91342)
Editorial (64)
Employer branding (21)
Employer resources (152)
Events (118972)
Executive appointments (1057)
FDA (20086)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1672)
Gene editing (224)
Generative AI (54)
Gene therapy (681)
GLP-1 (1035)
Government (4716)
Grass and pollen (6)
Guidances (403)
Healthcare (18968)
HIV (77)
Huntington's disease (53)
IgA nephropathy (93)
Immunology and inflammation (279)
Immuno-oncology (86)
Indications (173)
Infectious disease (3066)
Inflammatory bowel disease (204)
Inflation Reduction Act (14)
Influenza (135)
Intellectual property (282)
Interviews (317)
IPO (16656)
IRA (50)
Job creations (3646)
Job search strategy (1430)
JPM (58)
Kidney cancer (18)
Labor market (96)
Layoffs (557)
Leadership (37)
Legal (7953)
Liver cancer (99)
Longevity (32)
Lung cancer (752)
Lymphoma (421)
Machine learning (58)
Management (59)
Manufacturing (986)
MASH (179)
Medical device (13896)
Medtech (13989)
Mergers & acquisitions (20126)
Metabolic disorders (1451)
mRNA (193)
Multiple sclerosis (181)
NASH (17)
Neurodegenerative disease (395)
Neuropsychiatric disorders (101)
Neuroscience (3220)
Neurotech (1)
NextGen: Class of 2026 (6521)
Non-profit (4525)
Now hiring (75)
Obesity (679)
Opinion (283)
Ovarian cancer (206)
Pain (244)
Pancreatic cancer (286)
Parkinson's disease (351)
Partnered (33)
Patents (576)
Patient recruitment (635)
Peanut (61)
People (59431)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (21989)
Phase 2 (31071)
Phase 3 (23127)
Pipeline (7830)
Policy (308)
Postmarket research (2567)
Preclinical (9362)
Press Release (64)
Prostate cancer (286)
Psychedelics (52)
Radiopharmaceuticals (317)
Rare diseases (1027)
Real estate (5965)
Recruiting (70)
Regulatory (25229)
Reports (55)
Research institute (2410)
Resumes & cover letters (353)
Rett syndrome (36)
RNA editing (20)
RSV (88)
Schizophrenia (172)
Series A (278)
Series B (207)
Service/supplier (11)
Sickle cell disease (109)
Special edition (22)
Spinal muscular atrophy (165)
Sponsored (47)
Startups (3632)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (87)
The Weekly (61)
Vaccines (1076)
Venture capital (102)
Weight loss (437)
Women's health (120)
Worklife (20)
Date
Today (162)
Last 7 days (711)
Last 30 days (2805)
Last 365 days (30284)
2026 (10292)
2025 (30170)
2024 (35211)
2023 (40072)
2022 (51173)
2021 (55707)
2020 (54081)
2019 (46537)
2018 (35016)
2017 (32108)
2016 (31481)
2015 (37551)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29264)
2010 (27328)
Location
Africa (740)
Alabama (91)
Alaska (7)
Arizona (341)
Arkansas (14)
Asia (39584)
Australia (6484)
California (12747)
Canada (3647)
China (1291)
Colorado (546)
Connecticut (550)
Delaware (389)
Europe (85554)
Florida (1911)
Georgia (409)
Hawaii (3)
Idaho (62)
Illinois (1019)
India (88)
Indiana (581)
Iowa (23)
Japan (513)
Kansas (129)
Kentucky (49)
Louisiana (39)
Maine (75)
Maryland (1529)
Massachusetts (9076)
Michigan (353)
Minnesota (693)
Mississippi (6)
Missouri (143)
Montana (33)
Nebraska (29)
Nevada (138)
New Hampshire (84)
New Jersey (3376)
New Mexico (28)
New York (3350)
North Carolina (1613)
North Dakota (8)
Northern California (6355)
Ohio (378)
Oklahoma (23)
Oregon (41)
Pennsylvania (2571)
Puerto Rico (28)
Rhode Island (50)
South America (1112)
South Carolina (85)
South Dakota (2)
Southern California (5016)
Tennessee (206)
Texas (2015)
United States (45049)
Utah (379)
Vermont (1)
Virginia (304)
Washington D.C. (80)
Washington State (1024)
West Virginia (4)
Wisconsin (122)
Wyoming (2)
728,545 Results for "hygieia inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Hygieia Extends Series B Round to $22 Million with Participation from Strategic Investors
Hygieia is extending its Series B funding round to $22 million with a lead investment from Firstime Ventures and additional investment from two strategic partners.
May 2, 2023
·
3 min read
BioMidwest
UAT Group Subsidiary Launches New Hygieia Ageless Skin Care Line
Umbra Applied Technologies Group, Inc. announced that its subsidiary, The Dreaming Company, LLC, is re-branding and expanding its highly lauded Hygieia Skin care product suite as “Hygieia Ageless”.
August 12, 2022
·
4 min read
BioMidwest
Hygieia announces new CPT codes for autonomous insulin dose titration
Hygieia, a digital therapeutics company for insulin therapy, announces the American Medical Association (AMA) CPT Editorial Panel has approved two new Category III codes for autonomous insulin dose titration, which can be used for Hygieia’s d-Nav® Technology.
July 26, 2022
·
3 min read
BioMidwest
UAT Group Subsidiary, The Dreaming Company Announces Hygieia Eye Gel
Umbra Applied Technologies Group, Inc. announced that its subsidiary, The Dreaming Company, is expanding on its Hygieia product line with the launch of a new premium revitalizing eye gel.
August 2, 2022
·
4 min read
BioMidwest
Hygieia adds to team, continues rapid, national expansion of its d-Nav® Insulin Management Program
Hygieia adds to team, continues rapid, national expansion of its d-Nav® Insulin Management Program.
December 13, 2022
·
3 min read
Press Releases
Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.
March 25, 2026
·
3 min read
Business
Hygieia adds Metro Detroit Endocrinology Center as clinical partner for its d-Nav® Insulin Management Program
Hygieia adds Metro Detroit Endocrinology Center as clinical partner for its d-Nav® Insulin Management Program.
August 30, 2022
·
3 min read
Press Releases
Axogen, Inc. Reports First Quarter 2026 Financial Results
April 28, 2026
·
18 min read
Press Releases
Carlsmed, Inc. To Participate in Upcoming Investor Conferences - April 28, 2026
April 29, 2026
·
1 min read
Press Releases
Climb Bio, Inc. Announces $110.0 Million Private Placement
April 28, 2026
·
6 min read
1 of 72,855
Next
